|
Gastroenterologia Polskacontents of: 2009; 16/4- Expression of apoptotic proteins FasL, CPP-3, p53, and bcl-2 and their possible correlation with the progress of liver damage and biochemical disease activity in the course of chronic hepatitis type B
Sylwia Serafińska, Krzysztof Simon, Agnieszka Hałoń - The association between NK cells and T-lymphocyte subpopulations and fibrosis progression in chronic hepatitis C
Andrzej Gabriel, Bogdan Mazur, Michał Kukla, Adam Ziółkowski, Barbara Szczygieł, Krzysztof Tomaszek - Insulin resistance and response to interferon and ribavirin therapy in chronic hepatitis type C
Marta Wawrzynowicz-Syczewska, Igor Miroszniczenko, Łukasz Laurans, Krzysztof Jurczyk, Ewa Karpińska, Anna Boroń-Kaczmarska - Expressions of tumor necrosis factor-related apoptosis-inducing ligand and caspase-3 are not predictive factors of chronic hepatitis C therapy
Anna Piekarska, Robert Kubiak, Aleksandra Omulecka, Wiesław Szymczak, Janusz Piekarski - Evaluation of the circulatory system and the risk of cardiovascular morbidity and mortality in patients with nonalcoholicfatty liver disease
Kamila Wójcik, Elżbieta Jabłonowska, Aleksandra Omulecka, Jan Kuydowicz, Paulina Wejner-Mik, Anna Piekarska - Hepatotoxicity of antiretroviral therapy
Anita Olczak, Edyta Grąbczewska, Kornelia Karwowska - Angiogenesis in chronic viral hepatitis
Michał Kukla, Andrzej Gabriel, Marek Waluga, Rafał Bułdak, Włodzimierz Mazur - Some aspects of pathophysiology of liver fibrosis
Włodzimierz Mazur, Michał Kukla, Grzegorz Wagner, Jakub Kwiatkowski, Maciej Jabłkowski - Metabolic disturbances in patients with chronic HCV infection
Łukasz Laurans, Igor Miroszniczenko, Marta Wawrzynowicz-Syczewska - Current treatment of chronic hepatitis B
Magdalena M. Dąbrowska, Robert Flisiak - New perspectives in treatment of chronic hepatitis C
Anna Parfieniuk, Robert Flisiak - Therapeutic options for hepatocellular carcinoma
Piotr Małkowski, Dariusz Wasiak, Jarosław Czerwiński
« journal
|
|
|
|
|
